Klp Kapitalforvaltning As Stoke Therapeutics, Inc. Transaction History
Klp Kapitalforvaltning As
- $19.9 Billion
- Q1 2025
A detailed history of Klp Kapitalforvaltning As transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 5,700 shares of STOK stock, worth $53,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,700
Previous 5,700
-0.0%
Holding current value
$53,352
Previous $62,000
40.32%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STOK
# of Institutions
135Shares Held
60.4MCall Options Held
5.6KPut Options Held
142K-
Skorpios Trust6.91MShares$64.6 Million99.7% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$50.6 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.29MShares$49.5 Million13.01% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$48 Million0.56% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$43.4 Million0.37% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $369M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...